Drug profile · INN
mivacurium chloride
MIVACURIUM CHLORIDE
mivacurium chloride (MIVACURIUM CHLORIDE) is a muscle-type nicotinic acetylcholine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — mivacurium chloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
mivacurium chloride (MIVACURIUM CHLORIDE) is a muscle-type nicotinic acetylcholine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscle-type nicotinic acetylcholine receptor antagonist
Primary target: Muscle-type nicotinic acetylcholine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is mivacurium chloride?
mivacurium chloride (MIVACURIUM CHLORIDE) is a muscle-type nicotinic acetylcholine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for mivacurium chloride?
MIVACURIUM CHLORIDE is a marketed brand name for mivacurium chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mivacurium chloride?
mivacurium chloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.